Is digital health the Future?Are connected Diagnostics becoming mainstream?
March 9th 16:00 CET
Join us in a series of discussions centred around Digital Health and MedTech pioneers in 2023.
Let’s start the discussion with Esmeralda MEGALLY, CEO and Founder of Xsensio, an INPHO awarded company offering a new frontier in digital health by collecting a unique set of biological data.
Will 2023 see Digital Health become mainstream? What are the technological and social trends that could make it finally become mainstream after years of promising announcements claiming that the time has come for better prevention, better diagnostics and personalized medicine?
By 2025, it is estimated that 30% of acute care will move from Hospital & Doctors to home. To enable appropriate care in those conditions, we need more preventive, personalized, patient-centered and data-driven innovations. Despite the fact that the Biosensor Market is still relying on invasive and non-continuous solutions to gather health data, it is expected to reach €32B in 2024, growing at a CAGR of 8.3% since 2020.
Beyond the great expectations generated by Lab-on-chip devices that were supposed to give us access to predictive, preventative, personalised and participatory medicine, what are the latest digital innovations that will shape the future of diagnostics, prevention and treatment of diseases? Meet with Esmeralda Megally, CEO and co-founder of Xsensio, winner of the INPHO Venture Summit start-up award in 2022.
Mrs. Esmeralda MEGALLY
CEO and Founder
Esmeralda has several years of experience as manager at Boston-based investment firm Commons Capital where she was in charge of screening investment opportunities in a partnership with the Bill and Melinda Gates Foundation. She earned her MBA at the Massachusetts Institute of Technology (MIT), a B.S. and M.S. in Economics from ULB, Belgium, and an executive degree in management from EPFL.
Xsensio, is an innovation-driven digital health company building the breakthrough Lab-on-SkinTM wearable: a modular miniaturized sensing platform that will offer unique health insight through the continuous and real-time analysis of proteins and hormones at the surface of the skin during critical health events, to improve standard of care in a simple and minimally-invasive way.